RESEARCH-USE BIOSIMILAR ANTIBODY
Metelimumab
Monoclonal antibody · IgG4
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1.
TARGETTGFB1
YMonoclonal antibody
CATALOGSC-BS-383
CATALOG NUMBERSC-BS-383
MOLECULAR WEIGHTApprox. 145.02 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1.
Metelimumab is a recombinant research-use antibody directed against TGFB1.